fdaotc

45 results found.

Top Stocks matching your search for "fda otc"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 27, 2023

Super excited for tomorrow's ER Guidance Call ... See more

Jan, 21, 2023

They're FDA approved, have the best in class t... See more

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
RSLS

ReShape Lifesciences Inc.

-48.86%

$5.91 - $3.02

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 3, 2023

$LIPO looking fantastic with the lockup agreement ... See more

Jan, 4, 2023

Another one with FDA news like r/s name, with goo... See more

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
JSPR

Jasper Therapeutics Inc

3.78%

$1.85 - $1.92

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 13, 2023

$JSPR FDA approval here a few weeks ago, this baby isn’t going down,

Jan, 4, 2023

positive PURSUIT outcome and FDA approval would op... See more

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 27, 2023

Super excited for tomorrow's ER Guidance Call for our first ever FDA approved commercialized product, Briumvi!

Jan, 21, 2023

They're FDA approved, have the best in class treatment, and is more affordable than the others.

Dec, 30, 2022

$JAZZ $TGTX FDA APPROVED ON 12/28/22 . BUY/HOLD/ACCUMULATE

Dec, 30, 2022

$KALA up 46%, rallies 3rd day in a row following FDA acceptance of IND application of KPI-012 & $TGTX is up 13% continued momentum following MS drug approvals.

Dec, 30, 2022

Our best in class drug is FDA APPROVED.

Dec, 30, 2022

$TGTX $KALA $HOTH $NUWE TGTX on fire 🔥 and solid from fundamentals perspective after yesterday FDA approval of Multiple Sclerosis Billion dollar drug revenue potential.

Dec, 30, 2022

Great FDA approval news in a growing MS market with a need.

Dec, 30, 2022

$TGTX , absolutely amazing….Scumbag’s Bank of America analyst rated TG today as underperform $6….total joke….I guess the analyst is waiting for FDA approval…LOL ….stick to loans and mortgages….very bullish TG community Longs….

Dec, 29, 2022

$TGTX FDA approval for Billion dollar MS drug — great things in store 2023 $DRMA just officially dropped offering, makes me feel company has something good up it’s sleeve.

Dec, 29, 2022

.. FDA APPROVED ON 12/28/22 BEST IN CLASS .

RSLS

ReShape Lifesciences Inc.

-48.86%

$5.91 - $3.02

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 3, 2023

$LIPO looking fantastic with the lockup agreement and multiple possible fda announcements due soon.

Jan, 4, 2023

Another one with FDA news like r/s name, with good technical , reminds me of $RSLS $MSGM yesterday , which ran nice 7+ is the signal

JSPR

Jasper Therapeutics Inc

3.78%

$1.85 - $1.92

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 13, 2023

$JSPR FDA approval here a few weeks ago, this baby isn’t going down,

Jan, 4, 2023

positive PURSUIT outcome and FDA approval would open a multibillion-dollar commercial opportunity for Viveve.

Jan, 3, 2023

$BJDX .41 great entry ahead of FDA news just like $JSPR +600% monster run!